Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of Cochrane Systematic Reviews

Souvik Mitra, Willem P de Boode, Dany E Weisz, Prakeshkumar S Shah, Souvik Mitra, Willem P de Boode, Dany E Weisz, Prakeshkumar S Shah

Abstract

Background: Patent ductus arteriosus (PDA) is associated with significant morbidity and mortality in preterm infants. Several non-pharmacological, pharmacological, and surgical approaches have been explored to prevent or treat a PDA.

Objectives: To summarise Cochrane Neonatal evidence on interventions (pharmacological or surgical) for the prevention of PDA and related complications, and interventions for the management of asymptomatic and symptomatic PDA in preterm infants.

Methods: We searched the Cochrane Database of Systematic Reviews on 20 October 2022 for ongoing and published Cochrane Reviews on the prevention and treatment of PDA in preterm (< 37 weeks' gestation) or low birthweight (< 2500 g) infants. We included all published Cochrane Reviews assessing the following categories of interventions: pharmacological therapy using prostaglandin inhibitor drugs (indomethacin, ibuprofen, and acetaminophen), adjunctive pharmacological interventions, invasive PDA closure procedures, and non-pharmacological interventions. Two overview authors independently checked the eligibility of the reviews retrieved by the search, and extracted data from the included reviews using a predefined data extraction form. Any disagreements were resolved by discussion with a third overview author. Two overview authors independently assessed the methodological quality of the included reviews using the AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) tool. We reported the GRADE certainty of evidence as assessed by the respective review authors using summary of findings tables.

Main results: We included 16 Cochrane Reviews, corresponding to 138 randomised clinical trials (RCT) and 11,856 preterm infants, on the prevention and treatment of PDA in preterm infants. One of the 16 reviews had no included studies, and therefore, did not contribute to the results. Six reviews reported on prophylactic interventions for the prevention of PDA and included pharmacological prophylaxis with prostaglandin inhibitor drugs, prophylactic surgical PDA ligation, and non-pharmacologic interventions (chest shielding during phototherapy and restriction of fluid intake); one review reported on the use of indomethacin for the management of asymptomatic PDA; nine reviews reported on interventions for the management of symptomatic PDA, and included pharmacotherapy with prostaglandin inhibitor drugs in various routes and dosages, surgical PDA ligation, and adjunct therapies (use of furosemide and dopamine in conjunction with indomethacin). The quality of reviews varied. Two reviews were assessed to be high quality, seven reviews were of moderate quality, five of low quality, while two reviews were deemed to be of critically low quality. For prevention of PDA, prophylactic indomethacin reduces severe intraventricular haemorrhage (IVH; relative risk (RR) 0.66, 95% confidence interval (CI) 0.53 to 0.82; 14 RCTs, 2588 infants), and the need for invasive PDA closure (RR 0.51, 95% CI 0.37 to 0.71; 8 RCTs, 1791 infants), but it does not appear to affect the composite outcome of death or moderate/severe neurodevelopmental disability (RR 1.02, 95% CI 0.90 to 1.15; 3 RCTs, 1491 infants). Prophylactic ibuprofen probably marginally reduces severe IVH (RR 0.67, 95% CI 0.45 to 1.00; 7 RCTs, 925 infants; moderate-certainty evidence), and the need for invasive PDA closure (RR 0.46, 95% CI 0.22 to 0.96; 7 RCTs, 925 infants; moderate-certainty evidence). The evidence is very uncertain on the effect of prophylactic acetaminophen on severe IVH (RR 1.09, 95% CI 0.07 to 16.39; 1 RCT, 48 infants). Necrotising enterocolitis (NEC) was lower with both prophylactic surgical ligation (RR 0.25, 95% CI 0.08 to 0.83; 1 RCT, 84 infants), and fluid restriction (RR 0.43, 95% CI 0.21 to 0.87; 4 RCTs, 526 infants). For treatment of asymptomatic PDA, indomethacin appears to reduce the development of symptomatic PDA post-treatment (RR 0.36, 95% CI 0.19 to 0.68; 3 RCTs, 97 infants; quality of source review: critically low). For treatment of symptomatic PDA, all available prostaglandin inhibitor drugs appear to be more effective in closing a PDA than placebo or no treatment (indomethacin: RR 0.30, 95% CI 0.23 to 0.38; 10 RCTs, 654 infants; high-certainty evidence; ibuprofen: RR 0.62, 95% CI 0.44 to 0.86; 2 RCTs, 206 infants; moderate-certainty evidence; early administration of acetaminophen: RR 0.35, 95% CI 0.23 to 0.53; 2 RCTs, 127 infants; low-certainty evidence). Oral ibuprofen appears to be more effective in PDA closure than intravenous (IV) ibuprofen (RR 0.38, 95% CI 0.26 to 0.56; 5 RCTs, 406 infants; moderate-certainty evidence). High-dose ibuprofen appears to be more effective in PDA closure than standard-dose ibuprofen (RR 0.37, 95% CI 0.22 to 0.61; 3 RCTs, 190 infants; moderate-certainty evidence). With respect to adverse outcomes, compared to indomethacin administration, NEC appears to be lower with ibuprofen (any route; RR 0.68, 95% CI 0.49 to 0.94; 18 RCTs, 1292 infants; moderate-certainty evidence), oral ibuprofen (RR 0.41, 95% CI 0.23 to 0.73; 7 RCTs, 249 infants; low-certainty evidence), and with acetaminophen (RR 0.42, 95% CI 0.19 to 0.96; 4 RCTs, 384 infants; low-certainty evidence). However, NEC appears to be increased with a prolonged course of indomethacin versus a shorter course (RR 1.87, 95% CI 1.07 to 3.27; 4 RCTs, 310 infants).

Authors' conclusions: This overview summarised the evidence from 16 Cochrane Reviews of RCTs regarding the effects of interventions for the prevention and treatment of PDA in preterm infants. Prophylactic indomethacin reduces severe IVH, but does not appear to affect the composite outcome of death or moderate/severe neurodevelopmental disability. Prophylactic ibuprofen probably marginally reduces severe IVH (moderate-certainty evidence), while the evidence is very uncertain on the effect of prophylactic acetaminophen on severe IVH. All available prostaglandin inhibitor drugs appear to be effective in symptomatic PDA closure compared to no treatment (high-certainty evidence for indomethacin; moderate-certainty evidence for ibuprofen; low-certainty evidence for early administration of acetaminophen). Oral ibuprofen appears to be more effective in PDA closure than IV ibuprofen (moderate-certainty evidence). High dose ibuprofen appears to be more effective in PDA closure than standard-dose ibuprofen (moderate-certainty evidence). There are currently two ongoing reviews, one on fluid restriction for symptomatic PDA, and the other on invasive management of PDA in preterm infants.

Conflict of interest statement

SM is an Associate Editor, Cochrane Neonatal Group. However, he had no involvement in the editorial processing of this overview. He has also published medical articles related to the management of PDA in preterm infants.

WdB has published medical articles related to PDA in preterm infants. He was the project leader of the BeNeDuctus trial (Hundscheid 2023), a international, multicentre, randomised non‐inferiority trial of early treatment versus expectant management of patent ductus arteriosus in preterm infants (study protocol: Hundscheid 2018, and statistical analysis plan: Hundscheid 2021).

DW has no conflict of interest to declare.

PSS is an Associate Editor, Cochrane Neonatal Group. However, he had no involvement in the editorial processing of this overview.

Copyright © 2023 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane Collaboration.

Figures

1
1
Study selection flow diagram

References

References to included reviews Anabrees 2011

    1. Anabrees J, AlFaleh K. Fluid restriction and prophylactic indomethacin versus prophylactic indomethacin alone for prevention of morbidity and mortality in extremely low birth weight infants. Cochrane Database of Systematic Reviews 2011, Issue 7. Art. No: CD007604. [DOI: 10.1002/14651858.CD007604.pub2]
Barrington 2002
    1. Barrington KJ, Brion LP. Dopamine versus no treatment to prevent renal dysfunction in indomethacin-treated preterm newborn infants. Cochrane Database of Systematic Reviews 2002, Issue 3. Art. No: CD003213. [DOI: 10.1002/14651858.CD003213]
Bell 2014
    1. Bell EF, Acarregui MJ. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews 2014, Issue 12. Art. No: CD000503. [DOI: 10.1002/14651858.CD000503.pub3]
Bhola 2015
    1. Bhola K, Foster JP, Osborn DA. Chest shielding for prevention of a haemodynamically significant patent ductus arteriosus in preterm infants receiving phototherapy. Cochrane Database of Systematic Reviews 2015, Issue 11. Art. No: CD009816. [DOI: 10.1002/14651858.CD009816.pub2]
Brion 2001
    1. Brion LP, Campbell D. Furosemide for prevention of morbidity in indomethacin-treated infants with patent ductus arteriosus. Cochrane Database of Systematic Reviews 2001, Issue 3. Art. No: CD001148. [DOI: 10.1002/14651858.CD001148]
Cooke 2003
    1. Cooke L, Steer PA, Woodgate PG. Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database of Systematic Reviews 2003, Issue 1. Art. No: CD003745. [DOI: 10.1002/14651858.CD003745]
Evans 2021
    1. Evans P, O'Reilly D, Flyer JN, Soll R, Mitra S. Indomethacin for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database of Systematic Reviews 2021, Issue 1. Art. No: CD013133. [DOI: 10.1002/14651858.CD013133.pub2]
Fowlie 2010
    1. Fowlie PW, Davis PG, McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database of Systematic Reviews 2010, Issue 7. Art. No: CD000174. [DOI: 10.1002/14651858.CD000174.pub2]
Görk 2008
    1. Görk AS, Ehrenkranz RA, Bracken MB. Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No: CD006071. [DOI: 10.1002/14651858.CD006071.pub2]
Herrera 2007
    1. Herrera CM, Holberton JR, Davis PG. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No: CD003480. [DOI: 10.1002/14651858.CD003480.pub3]
Jasani 2022
    1. Jasani B, Mitra S, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database of Systematic Reviews 2020, Issue 1. Art. No: CD010061. [DOI: 10.1002/14651858.CD010061.pub4]
Malviya 2013
    1. Malviya MN, Ohlsson A, Shah SS. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database of Systematic Reviews 2013, Issue 3. Art. No: CD003951. [DOI: 10.1002/14651858.CD003951.pub3]
Mitra 2020a
    1. Mitra S, Scrivens A, Kursell AM, Disher T. Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants. Cochrane Database of Systematic Reviews 2020, Issue 12. Art. No: CD013278. [DOI: 10.1002/14651858.CD013278.pub2]
Mosalli 2008
    1. Mosalli R, AlFaleh K. Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No: CD006181. [DOI: 10.1002/14651858.CD006181.pub2]
Ohlsson 2020a
    1. Ohlsson A, Shah SS. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2020, Issue 1. Art. No: CD004213. [DOI: 10.1002/14651858.CD004213.pub5]
Ohlsson 2020b
    1. Ohlsson A, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database of Systematic Reviews 2020, Issue 2. Art. No: CD003481. [DOI: 10.1002/14651858.CD003481.pub8]
References to excluded reviews Mitra 2022
    1. Mitra S, Gardner CE, MacLellan A, Disher T, Styranko DM, Campbell-Yeo M, et al. Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis. Cochrane Database of Systematic Reviews 2022, Issue 3. Art. No: CD013846. [DOI: 10.1002/14651858.CD013846.pub2]
Additional references Adamska 2005
    1. Adamska E, Helwich E, Rutkowska M, Zacharska E, Piotrowska A. Comparison of the efficacy of ibuprofen and indomethacin in the treatment of patent ductus arteriosus in prematurely born infants [Porownanie ibuprofenu i indometacyny w leczeniu przetrwalego przewodu tetniczego u noworodkow urodzonych przedwczesnie]. Medycyna Wieku Rozwojowego 2005;9(3 Pt 1):335-54. [PMID: ]
Akar 2017
    1. Akar M, Yildirim TG, Sandal G, Bozdag S, Erdeve O, Altug N, et al. Does ibuprofen treatment in patent ductus arteriosus alter oxygen free radicals in premature infants? Cardiology in the Young 2017;27(3):507–11. [PMID: ]
Akisu 2001
    1. Akisu M, Ozyurek AR, Dorak C, Parlar A, Kultursay N. Enteral ibuprofen versus indomethacin in the treatment of patent ductus arteriosus in preterm newborn infants [Premature bebeklerde patent duktus arteriozusun tedavisinde enteral ibuprofen ve indometazinin etkinligi ve guvenilirligi]. Cocuk Sagligi ve Hastaliklari Dergisi 2001;44(1):56-60.
Al‐Lawama 2017
    1. Al-Lawama M, Alammori I, Abdelghani T, Badran E. Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus. Journal of International Medical Research 2017;46(2):811-8. [DOI: 10.1177/0300060517722698] [PMID: ]
Aly 2007
    1. Aly H, Lotfy W, Badrawi N, Ghawas M, Abdel-Meguid IE, Hammad TA. Oral ibuprofen and ductus arteriosus in premature infants: a randomized pilot study. American Journal of Perinatology 2007;24(5):267-70. [PMID: ]
Aranda 2009
    1. Aranda JV, Clyman R, Cox B, Van Overmeire B, Wozniak P, Sosenko I, et al. A randomized, double-blind, placebo-controlled trial of intravenous ibuprofen L-lysine for the early closure of non-symptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants. American Journal of Perinatology 2009;26(3):235-45. [DOI: 10.1055/s-0028-1103515] [PMID: ]
Asadpour 2018
    1. Asadpour N, Harandi PS, Hamidi M, Malek Ahmadi MR, Malekpour-Tehrani A. Comparison of the effect of oral acetaminophen and ibuprofen on patent ductus arteriosus closure in premature infants referred to Hajar hospital in Shahrekord in 2016-2017. Journal of Clinical Neonatology 2018;7(4):224-30. [DOI: 10.4103/jcn.JCN_47_18]
Asbagh 2015
    1. Asbagh PA, Zarkesh MR, Nili F, Sadat Nayeri FS, Naeem AT. Prophylactic treatment with oral paracetamol for patent ductus arteriosus in preterm infants: a randomized clinical trial. Tehran University Medical Journal 2015;73(2):86-92. []
Babaei 2018
    1. Babaei H, Nemati R, Daryoshi H. Closure of patent ductus arteriosus with oral acetaminophen in preterm neonates: a randomized trial. Biomedical Research and Therapy 2018;5(2):2034-44. [DOI: 10.15419/bmrat.v5i02.418]
Bada 1989
    1. Bada HS, Green RS, Pourcyrous M, Leffler CW, Korones SB, Magill HL, et al. Indomethacin reduces the risks of severe intraventricular hemorrhage. Journal of Pediatrics 1989;115(4):631-7. [PMID: ]
Baenziger 1999
    1. Baenziger O, Waldvogel K, Ghelfi D, Arbenz U, Fanconi S. Can dopamine prevent the renal side effects of indomethacin? A prospective randomized clinical study. Klinische Padiatrie 1999;211(6):438-41. [PMID: ]
Bagheri 2016
    1. Bagheri MM, Niknafs P, Sabsevari F, Torabi MH, Bahman Bijari B, Noroozi E, et al. Comparison of oral acetaminophen versus ibuprofen in premature infants with patent ductus arteriosus. Iranian Journal of Pediatrics 2016;26(4):e3975. [DOI: 10.5812/ijp.3975] [PMID: ]
Bagheri 2018
    1. Bagheri M, Bahman-Bijari B, Torabi-Nejad M, Niknafs P, Mousavi H, Fatemeh S, et al. Is prophylactic parenteral paracetamol effective to diminish incidence of PDA in preterm neonates? A randomized trial. Iranian Journal of Pediatrics 2018;28(4):e11735. [DOI: 10.5812/ijp.11735]
Bagnoli 2013
    1. Bagnoli F, Rossetti A, Messina G, Mori A, Casucci M, Tomasini B. Treatment of patent ductus arteriosus (PDA) using ibuprofen: renal side-effects in VLBW and ELBW newborns. Journal of Maternal-Fetal and Neonatal Medicine 2013;26(4):423-9. [DOI: 10.3109/14767058.2012.733775] [PMID: ]
Balachander 2020
    1. Balachander B, Mondal N, Bhat V, Adhisivam B, Kumar M, Satheesh S, et al. Comparison of efficacy of oral paracetamol versus ibuprofen for PDA closure in preterms - a prospective randomized clinical trial. Journal of Maternal-fetal & Neonatal Medicine 2020;33(9):1587-92. [DOI: 10.1080/14767058.2018.1525354] [PMID: ]
Ballabh 2010
    1. Ballabh P. Intraventricular hemorrhage in premature infants: mechanism of disease. Pediatric Research 2010;67(1):1-8. [DOI: 10.1203/PDR.0b013e3181c1b176] [PMID: ]
Bandstra 1988
    1. Bandstra ES, Montalvo BM, Goldberg RN, Pacheco I, Ferrer PL, Flynn J, et al. Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants. Pediatrics 1988;82(4):533-42. [PMID: ]
Barzilay 2012
    1. Barzilay B, Youngster I, Batash D, Keidar R, Baram S, Goldman M, et al. Pharmacokinetics of oral ibuprofen for patent ductus arteriosus closure in preterm infants. Archives of Disease in Childhood. Fetal Neonatal Edition 2012;97(2):116-9. [DOI: 10.1136/adc.2011.215160] [PMID: ]
Baud 2016
    1. Baud O, Maury L, Lebail F, Ramful D, El Moussawi F, Nicaise C, et al, PREMILOC trial study group. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial. Lancet 2016;387(10030):1827-36. [DOI: 10.1016/S0140-6736(16)00202-6]
Bell 1978
    1. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Annals of Surgery 1978;187(1):1-7. [DOI: 10.1097/00000658-197801000-00001] [PMID: ]
Bell 1980
    1. Bell EF, Warburton D, Stonestreet BS, Oh W. Effect of fluid administration on the development of symptomatic patent ductus arteriosus and congestive heart failure in premature infants. New England Journal of Medicine 1980;302(11):598-604. [DOI: 10.1056/NEJM198003133021103] [PMID: ]
Benitz 2010
    1. Benitz WE. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? Journal of Perinatology 2010;30(4):241-52. [DOI: 10.1038/jp.2010.3] [PMID: ]
Benitz 2016
    1. Benitz WE, Committee on Fetus and Newborn, American Academy of Pediatrics. Patent ductus arteriosus in preterm infants. Pediatrics 2016;137(1):e20153730. [DOI: 10.1542/peds.2015-3730] [PMID: ]
Bravo 2014
    1. Bravo MC, Cabaňas F, Riera J, Pérez-Fernández E, Quero J, Pérez-Rodriguez J, et al. Randomized controlled clinical trial of standard versus echocardiographically guided ibuprofen treatment for patent ductus arteriosus in preterm infants: a pilot study. Journal of Maternal-fetal & Neonatal Medicine 2014;27(9):904-9. [DOI: 10.3109/14767058.2013.846312] [PMID: ]
Brown 1979
    1. Brown ER. Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosus. Journal of Pediatrics 1979;95(5 Pt 2):865-6. [DOI: 10.1016/s0022-3476(79)80454-0] [PMID: ]
Cassady 1989
    1. Cassady G, Crouse DT, Kirklin JW, Strange MJ, Joiner CH, Godoy G, et al. A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. New England Journal of Medicine 1989;320(23):1511-6. [DOI: 10.1056/NEJM198906083202302] [PMID: ]
Cherif 2008
    1. Cherif A, Khrouf N, Jabnoun S, Mokrani C, Amara MB, Guellouze N, et al. Randomized pilot study comparing oral ibuprofen with intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus. Pediatrics 2008;122(6):e1256-61. [PMID: ]
Chotigeat 2003
    1. Chotigeat U, Jirapapa K, Layangkool T. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants. Chotmaihet Thangphaet [Journal of the Medical Association of Thailand] 2003;86(Suppl 3):S563-9. [PMID: ]
Christmann 2002
    1. Christmann V, Liem KD, Semmekrot BA, de Bor M. Changes in cerebral, renal and mesenteric blood flow velocity during continuous and bolus infusion of indomethacin. Acta Paediatrica 2002;91(4):440-6. [PMID: ]
Chung 2005
    1. Chung MY, Fang PC, Chung CH, Huang CB, Ou Yang MH, Chen CC. Risk factors for hemodynamically-unrelated cystic periventricular leukomalacia in very low birth weight premature infants. Journal of the Formosan Medical Association 2005;104(8):571-7. [PMID: ]
Clyman 2012
    1. Clyman RI, Couto J, Murphy GM. Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all? Seminars in Perinatology 2012;36(2):123-9. [DOI: 10.1053/j.semperi.2011.09.022] [PMID: ]
Coombs 1990
    1. Coombs RC, Morgan ME, Durbin GM, Booth IW, McNeish AS. Gut blood flow velocities in the newborn: effects of patent ductus arteriosus and parenteral indomethacin. Archives of Disease in Childhood 1990;65(10):1067-71. [DOI: 10.1136/adc.65.10_spec_no.1067] [PMID: ]
Cotton 1980
    1. Cotton RB, Hickey DE, Graham TP, Stahlman MT. Effect of early indomethacin (I) on ventilatory status of preterm infants with symptomatic patent ductus arteriosus (sPDA). Pediatric Research 1980;14:442.
Couser 1996
    1. Couser RJ, Ferrara TB, Wright GB, Cabalka AK, Schilling CG, Hoekstra RE, et al. Prophylactic indomethacin therapy in the first 24 hours of life for the prevention of patent ductus arteriosus in preterm infants treated prophylactically with surfactant in the delivery room. Journal of Pediaitrcs 1996;128(5 Pt 1):631-7. [PMID: ]
CTRI/2009/091/000041
    1. CTRI/2009/091/000041. RCT comparing indomethacin vs. no treatment for PDA on the basis of size in the first 24 hrs of life in preterm neonates between 28 to 32 weeks gestation requiring assisted ventilation. (first received 3 February 2009).
Dang 2013
    1. Dang D, Wang D, Zhang C, Zhou W, Zhou Q, Wu H. Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial. PloS One 2013;8(11):e77888. [DOI: 10.1371/journal.pone.0077888] [PMID: ]
Dani 2000
    1. Dani C, Bertini G, Reali MF, Murru P, Fabris C, Vangi V, et al. Prophylaxis of patent ductus arteriosus with ibuprofen in preterm infants. Acta Paediatrica 2000;89(11):1369-74. [PMID: ]
Dani 2005
    1. Dani C, Bertini G, Pezati M, Poggi C, Guerrini P, Martano C, et al. Prophylactic ibuprofen for the prevention of intraventricular hemorrhage among preterm infants: a multicenter, randomized study. Pediatrics 2005;115(6):1529-35. [DOI: 10.1542/peds.2004-1178] [PMID: ]
Dani 2012
    1. Dani C, Vangi V, Bertini G, Pratesi S, Lori I, Favelli F, et al. High-dose ibuprofen for patent ductus arteriosus in extremely preterm infants: a randomized controlled study. Clinical Pharmacology and Therapeutics 2012;91(4):590-6. [PMID: ]
Dani 2021
    1. Dani C, Lista G, Bianchi S, Mosca F, Schena F, Ramenghi L, et al. Intravenous paracetamol in comparison with ibuprofen for the treatment of patent ductus arteriosus in preterm infants: a randomized controlled trial. European Journal of Pediatrics 2021;180(3):807-16. [DOI: 10.1007/s00431-020-03780-8] [PMID: ]
Dash 2015
    1. Dash SK, Kabra NS, Avasthi BS, Sharma SR, Padhi P, Ahmed J. Enteral paracetamol or intravenous indomethacin for closure of patent ductus arteriosus in preterm neonates: a randomized controlled trial. Indian Pediatrics 2015;52(7):573-8. [DOI: 10.1007/s13312-015-0677-z] [PMID: ]
Davidson 2021
    1. Davidson JM, Ferguson J, Ivey E, Philip R, Weems MF, Talati AJ. A randomized trial of intravenous acetaminophen versus indomethacin for treatment of hemodynamically significant PDAs in VLBW infants. Journal of Perinatology 2021;41(1):93-9. [DOI: 10.1038/s41372-020-0694-1] [PMID: ]
De Carolis 2000
    1. De Carolis MP, Romagnoli C, Polimeni V, Piersigilli F, Zecca E, Papacci P, et al. Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants. European Journal of Pediatrics 2000;159(5):364-8. [PMID: ]
de Freitas Martins 2018
    1. Freitas Martins F, Ibarra Rios D, F Resende MH, Javed H, Weisz D, Jain A, et al. Relationship of patent ductus arteriosus size to echocardiographic markers of shunt volume. Journal of Pediatrics 2018;202:50-5.e3. [DOI: 10.1016/j.jpeds.2018.06.045] [PMID: ]
De Waal 2019
    1. De Waal K, Phad N, Stubbs M, Chen Y, Kluckow M. A double blind, randomised controlled pilot trial of early pharmacological treatment versus supportive management in preterm infants with a patent ductus arteriosus. Journal of Paediatrics and Child Health 2019;55:119. [DOI: 10.1111/jpc.14407_9]
Demir 2016
    1. Demir N, Peker E, Ece I, Balahoroglu R, Tuncer O. Efficacy and safety of rectal ibuprofen for ductus arteriosus closure in very low birth weight infants. European Journal of Pediatrics 2016;175(11):1705-6. [PMID: ]
Dice 2007
    1. Dice JE, Bhatia J. Patent ductus arteriosus: an overview. Journal of Pediatric Pharmacology Therapeutics 2007;12(3):138-46. [DOI: 10.5863/1551-6776-12.3.138] [PMID: ]
Ding 2014
    1. Ding YJ, Han B, Yang B, Zhu M. NT-proBNP plays an important role in the effect of ibuprofen on preterm infants with patent ductus arteriosus. European Review for Medical and Pharmacological Sciences 2014;18(18):2596-8. [PMID: ]
Dollberg 2005
    1. Dollberg S, Lusky A, Reichman B. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study. Journal of Pediatric Gastroenterology Nutrition 2005;40(2):184-8. [PMID: ]
Domanico 1994
    1. Domanico RS, Waldman JD, Lester LA, McPhillips HA, Catrambone JE, Covert RF. Prophylactic indomethacin reduces the incidence of pulmonary hemorrhage and patent ductus arteriosus in surfactant-treated infants < 1250 grams. Pediatric Research 1994;35:331A.
Drougia 2007
    1. Drougia A, Giapros V, Krallis N, Theocharis P, Nikaki A, Tzoufi M, et al. Incidence and risk factors for cerebral palsy in infants with perinatal problems: a 15-year review. Early Human Development 2007;83(8):541-7. [DOI: 10.1016/j.earlhumdev.2006.10.004] [PMID: ]
Ehrenkranz 2005
    1. Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA, et al, National Institutes of Child Health and Human Development Neonatal Research Network. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005;116(6):1353-60. [DOI: 10.1542/peds.2005-0249] [PMID: ]
El‐Farrash 2019
    1. El-Farrash RA, El Shimy MS, El-Sakka AS, Ahmed MG, Abdel-Moez DG. Efficacy and safety of oral paracetamol versus oral ibuprofen for closure of patent ductus arteriosus in preterm infants: a randomized controlled trial. Journal of Maternal-fetal & Neonatal Medicine 2019;32(21):3647-54. [DOI: 10.1080/14767058.2018.1470235] [PMID: ]
El‐Khuffash 2021
    1. El-Khuffash A, Bussmann N, Breatnach CR, Smith A, Tully E, Griffin J, et al. A pilot randomized controlled trial of early targeted patent ductus arteriosus treatment using a risk based severity score (the PDA RCT). Journal of Pediatrics 2021;229:127-33. [DOI: 10.1016/j.jpeds.2020.10.024] [PMID: ]
El‐Mashad 2017
    1. El-Mashad AE, El-Mahdy H, El Amrousy DE, Elgendy M. Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates. European Journal of Pediatrics 2017;176(2):233-40. [DOI: 10.1007/s00431-016-2830-7] [PMID: ]
Erdeve 2012
    1. Erdeve O, Yurttutan S, Altug N, Ozdemir R, Gokmen T, Dilmen U, et al. Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants. Archives of Disease in Childhood. Fetal and Neonatal Edition 2012;97(4):F279-83. [DOI: 10.1136/archdischild-2011-300532] [PMID: ]
Fajardo 1992
    1. Fajardo CA, Whyte RK, Steele BT. Effect of dopamine on failure of indomethacin to close the patent ductus arteriosus. Journal of Pediatrics 1992;121(5 Pt 1):771-5. [DOI: 10.1016/s0022-3476(05)81914-6] [PMID: ]
Fakhraee 2007
    1. Fakhraee SH, Badiee Z, Mojtahedzadeh S, Kazemian M, Kelishadi R. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Zhongguo Dang Dai Er Ke za Zhi [Chinese Journal of Contemporary Pediatrics] 2007;9(5):399-403. [PMID: ]
Fesharaki 2012
    1. Fesharaki HJ, Nayeri FS, Asbaq PA, Amini E, Sedagat M. Different doses of ibuprofen in the treatment of patent ductus arteriosus: a randomized controlled trial. Tehran University Medical Journal 2012;70(8):488-93.
Friedman 1976
    1. Friedman WF, Hirschklau MJ, Printz MP, Pitlick PT, Kirkpatrick SE. Pharmacologic closure of patent ductus arteriosus in the premature infant. New England Journal of Medicine 1976;295(10):526-9. [DOI: 10.1056/NEJM197609022951003] [PMID: ]
Gersony 1983
    1. Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. Journal of Pediatrics 1983;102(6):895-906. [DOI: 10.1016/s0022-3476(83)80022-5] [PMID: ]
Ghaderian 2019a
    1. Ghaderian M, Armanian AM, Sabri MR, Montaseri M. Low-dose intravenous acetaminophen versus oral ibuprofen for the closure of patent ductus arteriosus in premature neonates. Journal of Research in Medical Sciences 2019;24:13. [DOI: 10.4103/jrms.JRMS_631_17] [PMID: ]
Ghaderian 2019b
    1. Ghaderian M, Barekatain B, Dardashty AB. Comparison of oral acetaminophen with oral ibuprofen on closure of symptomatic patent ductus arteriosus in preterm neonates. Journal of Research in Medical Sciences 2019;24:96. [DOI: 10.4103/jrms.JRMS_197_19] [PMID: ]
Ghanem 2010
    1. Ghanem S, Mostafa M, Shafee M. Effect of oral ibuprofen on patent ductus arteriosus in premature newborns. Journal of the Saudi Heart Association 2010;22(1):7-12. [DOI: 10.1016/j.jsha.2010.01.002] [PMID: ]
Gillam‐Krakauer 2018
    1. Gillam-Krakauer M, Reese J. Diagnosis and management of patent ductus arteriosus. NeoReviews 2018;19(7):394-402. [DOI: 10.1542/neo.19-7-e394] [PMID: ]
Gimeno 2005
    1. Gimeno Navarro A, Cano Sanchez A, Fernandez Gilino C, Carrasco Moreno JI, Izquierdo Macian I, Gutierrez Laso A, et al. Ibuprofen versus indomethacin in the treatment of patent ductus arteriosus in preterm infants [Ibuprofeno frente a indometacina en el tratamiento del conducto arterioso persistente del prematuro]. Anales de Pediatria 2005;63(3):212-8. [PMID: ]
Gokmen 2011
    1. Gokmen T, Erdeve O, Altug N, Oguz SS, Uras N, Dilmen U. Efficacy and safety of oral verus intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus. Journal of Pediatrics 2011;158(4):549-54; Erratum in: Journal of Pediatrics; 2012;160(1):181. [10.1016/j.jpeds.2010.10.008] [PMID: ]
Gournay 2002
    1. Gournay V, Savagner C, Thiriez G, Kuster A, Rozé JC. Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet 2002;359(9316):1486-8. [DOI: 10.1016/S0140-6736(02)08424-6] [PMID: ]
Gournay 2004
    1. Gournay V, Roze JC, Daoud P, Cambonie G, Hascoet JM, Chamboux C, et al. Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet 2004;364(9449):1939-44. [DOI: 10.1016/S0140-6736(04)17476-X] [PMID: ]
Gournay 2011
    1. Gournay V. The ductus arteriosus: physiology, regulation, and functional and congenital anomalies. Archives of Cardiovascular Diseases 2011;104(11):578-85. [DOI: 10.1016/j.acvd.2010.06.006] [PMID: ]
Grèen 1989
    1. Grèen K, Drvota V, Vesterqvist O. Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol). Prostaglandins 1989;37(3):311–5. [PMID: ]
Gutierrez 1987
    1. Gutierrez NG, Lapasset M. Prophylactic indomethacin and the incidence of patent ductus arteriosus in preterm neonates. In: 3rd Argentinian Congress of Perinatology; 1987; Buenos Aires; Argentina. Vol. 62.
Hammerman 1987
    1. Hammerman C, Strates E, Komar K, Kim-chi B. Failure of prophylactic indomethacin to improve the outcome of the very low birth weight infant. Developmental Pharmacology and Therapeutics 1987;10(6):393-404. [PMID: ]
Hammerman 1990
    1. Hammerman C, Aramburo MJ. Prolonged indomethacin therapy for the prevention of recurrences of patent ductus arteriosus. Journal of Pediatrics 1990;117(5):771-6. [PMID: ]
Hammerman 1995
    1. Hammerman C, Glaser J, Schimmel MS, Ferber B, Kaplan M, Eidelman AI. Continuous versus multiple rapid infusions of indomethacin: effects on cerebral blood flow velocity. Pediatrics 1995;95(2):244-8. [PMID: ]
Hammerman 2008
    1. Hammerman C, Shchors I, Jacobson S, Schimmel MS, Bromiker R, Kaplan M, et al. Ibuprofen versus continuous indomethacin in premature neonates with patent ductus arteriosus: is the difference in the mode of administration? Pediatric Research 2008;64(3):291-7. [DOI: 10.1203/PDR.0b013e31817d9bb0] [PMID: ]
Hamrick 2020
    1. Hamrick SE, Sallmon H, Rose AT, Porras D, Shelton EL, Reese J, et al. Patent ductus arteriosus of the preterm infant. Pediatrics 2020;146(5):e20201209. [DOI: 10.1542/peds.2020-1209] [PMID: ]
Hanigan 1988
    1. Hanigan WC, Kennedy G, Roemisch F, Anderson R, Cusack T, Powers W. Administration of indomethacin for the prevention of periventricular haemorrhage in high-risk neonates. Journal of Pediatrics 1988;112(6):941-7. [PMID: ]
Hirt 2008
    1. Hirt D, Van Overmeire B, Treluyer JM, Langhendries JP, Marguglio A, Eisinger MJ, et al. An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamics study. British Journal of Clinical Pharmacology 2008;65(5):629-36. [DOI: 10.1111/j.1365-2125.2008.03118.x] [PMID: ]
Hochwald 2018
    1. Hochwald O, Mainzer G, Borenstein-Levin L, Jubran H, Dinur G, Zucker M, et al. Adding paracetamol to ibuprofen for the treatment of patent ductus arteriosus in preterm infants: a double-blind, randomized, placebo-controlled pilot study. American Journal of Perinatology 2018;35(13):1319-25. [DOI: 10.1055/s-0038-1653946] [PMID: ]
Hundscheid 2018
    1. Hundscheid T, Onland W, Overmeire B, Dijk P, Kaam AHL, Dijkman KP, et al. Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial). BMC Pediatrics 2018;18(1):262. [DOI: 10.1186/s12887-018-1215-7] [PMID: ]
Hundscheid 2019
    1. Hundscheid T, den Broek M, Lee R, Boode WP. Understanding the pathobiology in patent ductus arteriosus in prematurity - beyond prostaglandins and oxygen. Pediatric Research 2019;86(1):28-38. [DOI: 10.1038/s41390-019-0387-7] [PMID: ]
Hundscheid 2021
    1. Hundscheid T, Donders R, Onland W, Kooi EM, Vijlbrief DC, Vries WB, et al, BeNeDuctus trial study group. Multi-centre, randomised non-inferiority trial of early treatment versus expectant management of patent ductus arteriosus in preterm infants (the BeNeDuctus trial): statistical analysis plan. Trials 2021;22(1):627. [DOI: 10.1186/s13063-021-05594-x] [PMID: ]
Hundscheid 2023
    1. Hundscheid T, Onland W, Kooi EMW, Vijlbrief DC, Vries WB, Dijkman KP et al. Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus. N Engl J Med 2023;388(11):980-990. [DOI: 10.1056/NEJMoa2207418]
Härkin 2016
    1. Härkin P, Härmä A, Aikio O, Valkama M, Leskinen M, Saarela T, et al. Paracetamol accelerates closure of the ductus arteriosus after premature birth: a randomized trial. Journal of Pediatrics 2016;177:72-7. [DOI: 10.1016/j.jpeds.2016.04.066] [PMID: ]
ICCROP 2005
    1. International Committee for the Classification of Retinopathy of Prematurity (ICCROP). The international classification of retinopathy of prematurity revisited. Archives of Ophthalmology 2005;123(7):991-9. [DOI: 10.1001/archopht.123.7.991] [PMID: ]
Jafari 2019
    1. Jafari N, Mahdian Jouibari R, Ebadi A, Kamali K, Abdolahzadeh S, Hosseini M. Comparison between the safety and efficacy of iv paracetamol (acetaminophen) and iv ibuprofen in treating premature neonates with patent ductus arteriosus (PDA). Journal of Iranian Medical Council 2019;2(4):66-73. []
Jones 2011
    1. Jones LJ, Craven PD, Attia J, Thakkinstian A, Wright I. Network meta-analysis of indomethacin versus ibuprofen versus placebo for PDA in preterm infants. Archives of Disease in Childhood. Fetal and Neonatal Edition 2011;96(1):F45-52. [DOI: 10.1136/adc.2009.168682] [PMID: ]
Kaapa 1983
    1. Kaapa P, Lanning P, Koivisto M. Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome. Acta Paediatrica Scandinavica 1983;72(2):179-84. [DOI: 10.1111/j.1651-2227.1983.tb09693.x] [PMID: ]
Kalani 2016
    1. Kalani M, Shariat M, Khalesi N, Farahani Z, Ahmadi S. A comparison of early ibuprofen and indomethacin administration to prevent intraventricular hemorrhage among preterm infants. Acta Medica Iranica 2016;54(12):788-92. [PMID: ]
Kanmaz 2013
    1. Kanmaz G, Erdeve O, Canpolat FE, Oğuz SS, Uras N, Altug N, et al. Serum ibuprofen levels of extremely preterm infants treated prophylactically with oral ibuprofen to prevent patent ductus arteriosus. European Journal of Clinical Pharmacology 2013;69(5):1075-81. [DOI: 10.1007/s00228-012-1438-8] [PMID: ]
Kavvadia 2000
    1. Kavvadia V, Greenough A, Dimitriou G, Forsling ML. Randomized trial of two levels of fluid input in the perinatal period - effect on fluid balance, electrolyte and metabolic disturbances in ventilated VLBW infants. Acta Paediatrica 2000;89(2):237-41. [PMID: ]
Kluckow 2014
    1. Kluckow M, Jeffery M, Gill A, Evans N. A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus. Archives of Disease in Childhood. Fetal Neonatal Edition 2014;99(2):F99-104. [DOI: 10.1136/archdischild-2013-304695] [PMID: ]
Kluckow 2019
    1. Kluckow M, Carlisle H, Broom M, Woods P, Jeffery M, Desai D, et al. A pilot randomised blinded placebo-controlled trial of paracetamol for later treatment of a patent ductus arteriosus. Journal of Perinatology 2019;39(1):102-7. [DOI: 10.1038/s41372-018-0265-x] [PMID: ]
Knight 2011
    1. Knight D, Alkindi S, Buksh M, Kuschel C, Skinner J. Placebo-controlled pilot trial of indomethacin in preterm infants with a patent ductus arteriosus. Journal of Paediatrics and Child Health 2011;47:88.
Krauss 1989
    1. Krauss AN, Fatica N, Lewis BS, Cooper R, Thaler HT, Cirrincione C, et al. Pulmonary function in preterm infants following treatment with intravenous indomethacin. American Journal of Diseases of Children 1989;143(1):78-81. [DOI: 10.1001/archpedi.1989.02150130088021] [PMID: ]
Krueger 1987
    1. Krueger E, Mellander M, Bratton D, Cotton R. Prevention of symptomatic patent ductus arteriosus with a single dose of indomethacin. Journal of Pediatrics 1987;111(5):749-54. [PMID: ]
Kumar 2020
    1. Kumar A, Gosavi RS, Sundaram V, Oleti TP, Krishnan A, Kiran S, et al. Oral paracetamol vs oral ibuprofen in patent ductus arteriosus: a randomized, controlled, noninferiority trial. Journal of Pediatrics 2020;222:79-84.e2. [DOI: 10.1016/j.jpeds.2020.01.058] [PMID: ]
Lago 2002
    1. Lago P, Bettiol T, Salvadori S, Pitassi I, Vianello A, Chiandetti L, et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. European Journal of Pediatrics 2002;161(4):202-7. [PMID: ]
Lago 2014
    1. Lago P, Salvadori S, Opocher F, Ricato S, Chiandetti L, Frigo AC. Continuous infusion of ibuprofen for treatment of patent ductus arteriosus in very low birth weight infants. Neonatology 2014;105(1):46-54. [DOI: 10.1159/000355679] [PMID: ]
Lee 2003
    1. Lee J, Rajadurai VS, Tan KW, Wong KY, Wong EH, Leong JY. Randomized trial of prolonged low-dose versus conventional-dose indomethacin for treating patent ductus arteriosus in very low birth weight infants. Pediatrics 2003;112(2):345-50. [PMID: ]
Lin 2012
    1. Lin XZ, Chen HQ, Zheng Z, Li YD, Lai JD, Huang LH. Therapeutic effect of early administration of oral ibuprofen in very low birth weight infants with patent ductus arteriosus. Chinese Journal of Contemporary Pediatrics 2012;14(7):502-5. [PMID: ]
Lin 2017
    1. Lin YJ, Chen CM, Rehan VK, Florens A, Wu SY, Tsai ML, et al. Randomized trial to compare renal function and ductal response between Indomethacin and ibuprofen treatment in extremely low birth weight infants. Neonatology 2017;111(3):195–202. [DOI: 10.1159/000450822] [PMID: ]
Lorenz 1982
    1. Lorenz JM, Kleinman LI, Kotagal UR, Reller MD. Water balance in very low-birth-weight infants: relationship to water and sodium intake and effect on outcome. Journal of Pediatrics 1982;101(3):423-32. [PMID: ]
Lundh 2017
    1. Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L. Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews 2017, Issue 2. Art. No: MR000033. [DOI: 10.1002/14651858.MR000033.pub3]
Mahony 1982
    1. Mahony L, Carnero V, Brett C, Heymann MA, Clyman RI. Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants. New England Journal of Medicine 1982;306(9):506–10. [DOI: 10.1056/NEJM198203043060903] [PMID: ]
Mahony 1985
    1. Mahony L, Caldwell RL, Girod DA, Hurwitz RA, Jansen RD, Lemons JA, et al. Indomethacin therapy on the first day of life in infants with very low birth weight. Journal of Pediatrics 1985;106:801-5. [PMID: ]
Meena 2020
    1. Meena V, Meena DS, Rathore PS, Chaudhary S, Soni JP. Comparison of the efficacy and safety of indomethacin, ibuprofen, and paracetamol in the closure of patent ductus arteriosus in preterm neonates - a randomized controlled trial. Annals of Pediatric Cardiology 2020;13(2):130-5. [DOI: 10.4103/apc.APC_115_19] [PMID: ]
Ment 1985
    1. Ment LR, Duncan CC, Ehrenkranz RA, Kleinman CS, Pitt BR, Taylor KJ, et al. Randomized indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight infants. Journal of Pediatrics 1985;107(6):937-43. [PMID: ]
Ment 1988
    1. Ment LR, Duncan CC, Ehrenkranz RA, Kleinman CS, Taylor KJ, Scott DT, et al. Randomized low-dose indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight neonates. Journal of Pediatrics 1988;112(6):948-55. [PMID: ]
Ment 1994a
    1. Ment LR, Oh W, Ehrenkranz RA, Phillip AG, Vohr B, Allan W, et a. Low-dose indomethacin therapy and extension of intraventricular hemorrhage: a multicenter randomized trial. Journal of Pediatrics 1994;124(6):951-5. [PMID: ]
Ment 1994b
    1. Ment LR, Oh W, Ehrenkranz RA, Phillip AG, Vohr B, Allan W, et al. Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics 1994;93(4):543-50. [PMID: ]
Merritt 1981
    1. Merritt TA, Harris JP, Roghmann K, Wood B, Campanella V, Alexson C, et al. Early closure of the patent ductus arteriosus in very low-birth-weight infants: a controlled trial. Journal of Pediatrics 1981;99(2):281-6. [DOI: 10.1016/s0022-3476(81)80479-9] [PMID: ]
Mitra 2018
    1. Mitra S, Florez ID, Tamayo ME, Mbuagbaw L, Vanniyasingam T, Veroniki AA, et al. Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. JAMA 2018;319(12):1221-38. [DOI: 10.1001/jama.2018.1896] [PMID: ]
Mitra 2022a
    1. Mitra S, Weisz D, Jain A, Jong G'. Management of the patent ductus arteriosus in preterm infants. Paediatrics and Child Health 2022;27(1):63-4. [DOI: 10.1093/pch/pxab085] [PMID: ]
Monset‐Couchard 1983
    1. Monset-Couchard M, Dias-Mançano D, Murat I, Relier JP. Controlled trial of intravenous lyophilized indomethacin in the treatment of persistent ductus arteriosus in premature infants. Pediatrie 1983;38(6):365-77. [PMID: ]
Morales‐Suarez 1994
    1. Morales-Suarez M, Sanchez-Gil T, Lemus-Varela L. Low dose indomethacin for prevention of intraventricular hemorrhage in the preterm infant with mechanical ventilation: final report of a randomized study [Estudio comparavito de dosis baja de indometacina profilactica para hemorragia subependimaria/intraventricular en neonatos pretermino con ventilation mecanica]. Boletin Medico del Hospital Infantil de Mexico 1994;51:389–94.
Mosca 1997
    1. Mosca F, Bray M, Lattanzio M, Fumagalli M, Tosetto C. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. Journal of Pediatrics 1997;131(4):549-54. [PMID: ]
Nestrud 1980
    1. Nestrud RM, Hill DE, Arrington RW, Beard AG, Dungan WT, Lau PY, et al. Indomethacin treatment in patent ductus arteriosus. A double-blind study utilizing indomethacin plasma levels. Developmental Pharmacology and Therapeutics 1980;1(2-3):125-36. [PMID: ]
Neu 1981
    1. Neu J, Ariagno RL, Johnson JD, Pitlick PT, Cohen RS, Beets CL, et al. A double blind study of the effects of oral indomethacin in preterm infants with patent ductus arteriosus who failed medical management. Pediatric Pharmacology (New York) 1981;1(3):245-9. [PMID: ]
Oboodi 2020
    1. Oboodi R, Najib KS, Amoozgar H, Pourarian S, Moghtaderi M, Mehdizadegan N, et al. Positive tendency toward synchronous use of acetaminophen and ibuprofen in treating patients with patent ductus arteriosus. Türk Kardiyoloji Derneği Arşivi 2020;48(6):605-12. [DOI: 10.5543/tkda.2020.03902] [PMID: ]
Ohlsson 1993
    1. Ohlsson A, Bottu J, Govan J, Ryan ML, Fong K, Myhr T. Effect of indomethacin on cerebral blood flow velocities in very low birth weight neonates with a patent ductus arteriosus. Developmental Pharmacology Therapeutics 1993;20(1-2):100–6. [PMID: ]
Ohlsson 2020
    1. Ohlsson A, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database of Systematic Reviews 2020, Issue 1. Art. No: CD010061. [DOI: 10.1002/14651858.CD010061.pub4]
Oncel 2014
    1. Oncel MY, Yurttutan S, Erdeve O, Uras N, Altug N, Oguz SS, et al. Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial. Journal of Pediatrics 2014;164(3):510-4.e1. [DOI: 10.1016/j.jpeds.2013.11.008] [PMID: ]
Osborn 2003
    1. Osborn DA, Evans N, Kluckow M. Effect of early targeted indomethacin on the ductus arteriosus and blood flow to the upper body and brain in the preterm infant. Archives of Disease in Childhood. Fetal & Neonatal Edition 2003;88(6):F477-82. [DOI: 10.1136/fn.88.6.f477] [PMID: ]
Papile 1978
    1. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1500 gm. Journal of Pediatrics 1978;92(4):529-34. [DOI: 10.1016/s0022-3476(78)80282-0] [PMID: ]
Patel 1995
    1. Patel J, Marks KA, Roberts I, Azzopardi D, Edwards AD. Ibuprofen treatment of patent ductus arteriosus. Lancet 1995;346(8969):255. [PMID: ]
Patel 2000
    1. Patel J, Roberts I, Azzopardi D, Hamilton P, Edwards AD. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatric Research 2000;47(1):36-42. [PMID: ]
Pezzati 1999
    1. Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubatelli FF. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. Journal of Pediatrics 1999;135(6):733-8. [PMID: ]
Pistulli 2014
    1. Pistulli E, Hamiti A, Buba S, Hoxha A, Kelmendi N, Vyshka G. The association between patent ductus arteriosus and perinatal infection in a group of low birth weight preterm infants. Iranian Journal of Pediatrics 2014;24(1):42-8. [PMID: ]
Plavka 2001
    1. Plavka R, Svihovec P, Borek I, Biolek J, Kostirova M, Liska K, et al. Ibuprofen vs. indomethacin in the treatment of patent ductus arteriosus (PDA) in very premature neonates. Pediatric Research 2001;49:375A. [CENTRAL: CN-00710252]
Pourarian 2008
    1. Pourarian SH, Pishva N, Madani A, Rastegari M. Comparison of oral ibuprofen and indomethacin on closure of patent ductus arteriosus in preterm infants. Eastern Mediterranean Health Journal 2008;14(2):360-5. [PMID: ]
Pourarian 2015
    1. Pourarian S, Takmil F, Cheriki S, Amoozgar H. The effect of oral high-dose ibuprofen on patent ductus arteriosus closure in preterm infants. American Journal of Perinatology 2015;32(12):1158-63. [DOI: 10.1055/s-0035-1551671] [PMID: ]
Puckett 1985
    1. Puckett CG, Cox MA, Haskins KS, Fisher DJ. Prophylactic indomethacin (I) for the prevention of patent ductus arteriosus (PDA). Pediatric Research 1985;19(4):358.
Rennie 1986
    1. Rennie JM, Doyle J, Cooke RW. Early administration of indomethacin to preterm infants. Archives of Disease in Childhood 1986;61(3):233-8. [PMID: ]
Rennie 1991
    1. Rennie JM, Cooke RW. Prolonged low dose indomethacin for persistent ductus arteriosus of prematurity. Archives of Disease in Childhood 1991;66(1 Spec No):55-8. [DOI: 10.1136/adc.66.1_spec_no.55] [PMID: ]
Rhodes 1988
    1. Rhodes PG, Ferguson MG, Reddy NS, Joransen JA, Gibson J. Effects of prolonged versus acute indomethacin therapy in very low birth-weight infants with patent ductus arteriosus. European Journal of Pediatrics 1988;147(5):481-4. [PMID: ]
Romagnoli 1997
    1. Romagnoli C, Zecca E, Papacci P, De Carolis MP, Giannini R, Gallini F, et al. Furosemide does not prevent indomethacin-induced renal side effects in preterm infants. Clinical Pharmacology and Therapeutics 1997;62(2):181-6. [PMID: ]
Rosenfeld 1986
    1. Rosenfeld W, Sadhev S, Brunot V, Jhaveri R, Zabaleta I, Evans H. Phototherapy effect on the incidence of patent ductus arteriosus in premature infants: prevention with chest shielding. Pediatrics 1986;78(1):10-4. [PMID: ]
Rudd 1983
    1. Rudd P, Montanez P, Hallidie-Smith K, Silverman M. Indomethacin treatment for patent ductus arteriosus in very low birthweight infants: double blind trial. Archives of Disease in Childhood 1983;58(4):267-70. [DOI: 10.1136/adc.58.4.267] [PMID: ]
Salama 2008
    1. Salama H, Alsisi A, Al-Rifai H, Shaddad A, Samawal L, Habboub L, et al. A randomized controlled trial on the use of oral ibuprofen to close patent ductus arteriosus in premature infants. Journal of Neonatal-perinatal Medicine 2008;1(3):153-8.
Sangtawesin 2006
    1. Sangtawesin V, Sangtawesin C, Raksasinborisut C, Sathirakul K, Kanjanapattanakul W, Khorana M, et al. Oral ibuprofen prophylaxis for symptomatic patent ductus arteriosus of prematurity. Journal of the Medical Association of Thailand 2006;89(3):314-20. [PMID: ]
Sangtawesin 2008
    1. Sangtawesin C, Sangtawesin V, Lertsutthiwong W, Kanjanapattanakul W, Khorana M, Ayudhaya JK. Prophylaxis of symptomatic patent ductus arteriosus with oral ibuprofen in very low birth weight infants. Journal of the Medical Association of Thailand 2008;91:S28-34. [PMID: ]
Schindler 2021
    1. Schindler T, Smyth J, Bolisetty S, Michalowski J, Mallitt KA, Singla A, et al. Early PARacetamol (EPAR) trial: a randomized controlled trial of early paracetamol to promote closure of the ductus arteriosus in preterm infants. Neonatology 2021;118(3):274-82. [DOI: 10.1159/000515415] [PMID: ]
Schmidt 2001
    1. Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S, et al, trial of Indomethacin Prophylaxis in Preterms Investigators. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. New England Journal of Medicine 2001;344(26):1966-72. [DOI: 10.1056/NEJM200106283442602] [PMID: ]
Schünemann 2013
    1. Schünemann H, Broek J, Guyatt G, Oxman A, editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from .
Seri 1984
    1. Seri I, Tulassay T, Kiszel J, Csomor S. The use of dopamine for the prevention of the renal side effects of indomethacin in premature infants with patent ductus arteriosus. International Journal of Pediatric Nephrology 1984;5(4):209-14. [PMID: ]
Seyberth 1983
    1. Seyberth HW, Rascher W, Hackenthal R, Wille L. Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very low birth weight infants with symptomatic ductus arteriosus. Journal of Pediatrics 1983;103(6):979–84. [DOI: 10.1016/s0022-3476(83)80736-7] [PMID: ]
Shaffer 2019
    1. Shaffer ML, Baud O, Lacaze-Masmonteil T, Peltoniemi OM, Bonsante F, Watterberg KL. Effect of prophylaxis for early adrenal insufficiency using low-dose hydrocortisone in very preterm infants: an individual patient data meta-analysis. Journal of Pediatrics 2019;207:136-42. [DOI: 10.1016/j.jpeds.2018.10.004] [PMID: ]
Shahmirzadi 2021
    1. Shahmirzadi G, Nooripour S, Ziari A, Danaei N. Comparison of gastrointestinal complications of paracetamol and ibuprofen in the management of infants with patent ductus arteriosus: a randomized clinical trial study. International Journal of Preventive Medicine 2021;12:48. [PMID: ]
Shea 2017
    1. Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ 2017;358:j4008. [DOI: 10.1136/bmj.j4008] [PMID: ]
Shepherd 2018
    1. Shepherd E, Salam RA, Middleton P, Han S, Makrides M, McIntyre S, et al. Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews. Cochrane Database of Systematic Reviews 2018, Issue 6. Art. No: CD012409. [DOI: 10.1002/14651858.CD012409.pub2]
Sosenko 2012
    1. Sosenko IR, Fajardo MF, Claure N, Bancalari E. Timing of patent ductus arteriosus treatment and respiratory outcome in premature infants: a double-blind randomized controlled trial. Journal of Pediatrics 2012;160(6):929-35.e1. [DOI: 10.1016/j.jpeds.2011.12.031] [PMID: ]
Stavel 2017
    1. Stavel M, Wong J, Cieslak Z, Sherlock R, Claveau M, Shah PS. Effect of prophylactic indomethacin administration and early feeding on spontaneous intestinal perforation in extremely low-birth-weight infants. Journal of Perinatolgy 2017;37(2):188-93. [DOI: 10.1038/jp.2016.196] [PMID: ]
Su 2003
    1. Su PH, Chen JY, Su CM, Huang TC, Lee HS. Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Pediatrics International 2003;45(6):665-70. [PMID: ]
Su 2008
    1. Su BH, Lin HC, Chiu HY, Hsieh HY, Chen HH, Tsai YC. Comparison of ibuprofen and indomethacin for early-targeted treatment of patent ductus arteriosus in extremely premature infants: a randomised controlled trial. Archives of Disease in Childhood. Fetal and Neonatal Edition 2008;93(2):F94-9. [DOI: 10.1136/adc.2007.120584] [PMID: ]
Supapannachart 1999
    1. Supapannachart S, Khowsathit P, Patchakapati B. Indomethacin prophylaxis for patent ductus arteriosus (PDA) in infants with a birth weight of less than 1250 grams. Journal of the Medical Associaition of Thailand 1999;82(Suppl 1):S87-91. [PMID: ]
Supapannachart 2002
    1. Supapannachart S, Limrungsikul A, Khowsathit P. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital. Chotmaihet Thangphaet [Journal of the Medical Association of Thailand] 2002;85(Suppl 4):S1252-8. [PMID: ]
Tammela 1992
    1. Tammela OKT, Koivisto ME. Fluid restriction for preventing bronchopulmonary dysplasia? Reduced fluid intake during the first weeks of life improves the outcome of low-birth-weight infants. Acta Paediatrica 1992;81(3):207-12. [PMID: ]
Tammela 1999
    1. Tammela O, Ojala R, Iivainen T, Lautamatti L, Pokela M, Janas M, et al. Short versus prolonged indomethacin therapy for patent ductus arteriosus in preterm infants. Journal of Pediatrics 1999;134(5):552-7. [PMID: ]
Tauber 2020
    1. Tauber KA, King R, Colon M. Intravenous acetaminophen vs intravenous ibuprofen to close a patent ductus arteriosus closure: a pilot randomized controlled trial. Health Science Reports 2020;3(3):e183. [DOI: 10.1002/hsr2.183] [PMID: ]
Travadi 2006
    1. Travadi J, Simmer K, Ramsay J, Doherty D, Hagan R. Patent ductus arteriosus in extremely preterm infants receiving phototherapy: does shielding the chest make a difference? A randomised, controlled trial. Acta Paediatrica 2006;95(11):1418-23. [PMID: ]
Valaes 1980
    1. Valaes T, Moylan FM, Cohn H, Chung K, Nagpaul K, Chrenoff HL, et al. Incidence and significance of PDA in preterm infants (PTI) and controlled blind trial of indomethacin (IND). Pediatric Research 1980;14:452.
Van den Anker 2018
    1. Van den Anker JN, Allegaert K. Acetaminophen in the neonatal intensive care unit: shotgun approach or silver bullet. Journal of Pediatrics 2018;198:10-1. [DOI: 10.1016/j.jpeds.2018.02.046] [PMID: ]
Van Overmeire 1997
    1. Van Overmeire B, Follens I, Hartmann S, Creten WL, Van Acker KJ. Treatment of patent ductus arteriosus with ibuprofen. Archives of Disease in Childhood. Fetal and Neonatal Edition 1997;76(3):F179-84. [PMID: ]
Van Overmeire 2000
    1. Van Overmeire B, Smets K, Lecoutere D, Van de Broek H, Weyler J, De Groote K, et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. New England Journal of Medicine 2000;343(10):674-81. [DOI: 10.1056/NEJM200009073431001] [PMID: ]
Van Overmeire 2001
    1. Van Overmeire B, Van De Broek H, Van Laer P, Weyler J, Vanhaesebrouck P. Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome. Journal of Pediatrics 2001;138(2):205-11. [DOI: 10.1067/mpd.2001.110528] [PMID: ]
Van Overmeire 2004
    1. Van Overmeire B, Allegaert K, Casaer A, Debauche C, Decaluwe W, Jespers A, et al. Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2004;364(9449):1945-9. [DOI: 10.1016/S0140-6736(04)17477-1] [PMID: ]
Vargas‐Origel 1986
    1. Vargas-Origel A, Cruz-Anguiano V, López-Montaño A. Indomethacin and furosemide in closure of ductus arteriosus [Indometacina y furosemide en el cierre del conducto arterioso]. Boletin Medico del Hospital Infantil de Mexico 1986;43(8):482-8. [PMID: ]
Vincer 1987
    1. Vincer M, Allen A, Evans J, Nwaesei C, Stinson D, Rees E, et al. Early intravenous indomethacin prolongs respiratory support in very low birth weight infants. Acta Paediatrica Scandinavica 1987;76(6):894-7. [PMID: ]
von Stockhausen 1980
    1. Stockhausen HB, Struve M. Effects of highly varying parenteral fluid intakes in premature and newborn infants during the first three days of life (author's transl) [Die Auswirkungen einer stark unterschiedlichen parenteralen Flussigkeitszufuhr bei Fruh- und Neugeborenen in den ersten drei Lebenstagen]. Klinische Pädiatrie 1980;192(6):539-46. [PMID: ]
Weesner 1987
    1. Weesner K, Dillard R, Boyle R, Block S. Prophlactic treatment of asymptomatic patent ductus arteriosus in premature infants with respiratory distress syndrome. Southern Medical Journal 1987;80(6):706-8. [PMID: ]
Weisz 2014
    1. Weisz DE, More K, McNamara PJ, Shah PS. PDA ligation and health outcomes: a meta-analysis. Pediatrics 2014;133(4):e1024-46. [DOI: 10.1542/peds.2013-3431] [PMID: ]
Wolf 1989
    1. Wolf WM, Snover DC, Leonard AS. Localized intestinal perforation following intravenous indomethacin in premature infants. Journal of Pediatric Surgery 1989;24(4):409–10. [DOI: 10.1016/s0022-3468(89)80284-2] [PMID: ]
Yadav 2014
    1. Yadav S, Agarwal S, Maria A, Dudeja A, Dubey NK, Anand P, et al. Comparison of oral ibuprofen with oral indomethacin for PDA closure in Indian preterm neonates: a randomized controlled trial. Pediatric Cardiology 2014;35(5):824-30. [DOI: 10.1007/s00246-014-0861-2] [PMID: ]
Yanagi 1981
    1. Yanagi RM, Wilson A, Newfeld EA, Aziz KU, Hunt CE. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study. Pediatrics 1981;67(5):647-52. [PMID: ]
Yang 2016
    1. Yang B, Gao X, Ren Y, Wang Y, Zhang Q. Oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants: a randomized controlled trial. Experimental and Therapeutic Medicine 2016;12(4):2531-6. [DOI: 10.3892/etm.2016.3676] [PMID: ]
Yaseen 1997
    1. Yaseen H, al Umran K, Ali H, Rustum M, Darwich M, al-Faraidy A. Effects of early indomethacin administration on oxygenation and surfactant requirement in low birth weight infants. Journal of Tropical Pediatrics 1997;43(1):42-6. [PMID: ]
Yeh 1981
    1. Yeh TF, Luken JA, Thalji A, Raval D, Carr I, Pildes RS. Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus - a double blind controlled study. Journal of Pediatrics 1981;98(1):137-45. [DOI: 10.1016/s0022-3476(81)80560-4] [PMID: ]
Yeh 1982
    1. Yeh TF, Wilks A, Singh J, Betkerur M, Lilien L, Pildes RS. Furosemide prevents the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus. Journal of Pediatrics 1982;101(3):433-7. [PMID: ]
Zonnenberg 2012
    1. Zonnenberg I, Waal K. The definition of a haemodynamic significant duct in randomized controlled trials: a systematic literature review. Acta Paediatrica 2012;101(3):247-51. [DOI: 10.1111/j.1651-2227.2011.02468.x] [PMID: ]
References to other published versions of this review Mitra 2020b
    1. Mitra S, Boode WP, Weisz DE, Shah PS. Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of Cochrane Systematic Reviews. Cochrane Database of Systematic Reviews 2020, Issue 4. Art. No: CD013588. [DOI: 10.1002/14651858.CD013588]

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera